Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Enovis Corporation Common Stock (NY:ENOV)

36.06 +0.33 (+0.92%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 Next >
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Enovis (NYSE:ENOV)
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
3 Small-Cap Stocks with Bad Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Where Enovis Stands With Analysts
Via Benzinga
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.3% year on year to $558.8 million. The company’s full-year revenue... 
Via StockStory
Enovis Announces First Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting results tomorrow before market hours. Here’s what to look for. 
Via StockStory
3 Dawdling Stocks in Hot Water
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
1 Unprofitable Stock with Competitive Advantages and 2 to Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Reasons to Sell ENOV and 1 Stock to Buy Instead
What a brutal six months it’s been for Enovis. The stock has dropped 22.5% and now trades at $31.96, rattling many shareholders. This might have investors contemplating their next move. 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
From Enovis Corporation
Via GlobeNewswire
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season. 
Via StockStory
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Bausch + Lomb (NYSE:BLCO) and its peers. 
Via StockStory
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
From Enovis Corporation
Via GlobeNewswire
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to... 
From Enovis Corporation
Via GlobeNewswire
3 Stocks Under $50 in the Doghouse
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. 
Via StockStory
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (NASDAQ:STAA) and the best... 
Via StockStory
Enovis (NYSE:ENOV) Exceeds Q4 Expectations
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 23.3% year on year to $561 million. On the other hand, the... 
Via StockStory
Enovis Announces Fourth Quarter and Full Year 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Planned CEO Succession Process
From Enovis Corporation
Via GlobeNewswire
Enovis (ENOV) Q4 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Announces Leadership Change to International Surgical Business
From Enovis Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.